disease 3,767 words KG: ent-dise-64281c22
Contents

Cerebral Small Vessel Disease

Disease Info
Post-infectious CSVDCertain infections (varicella-zoster virus, HIV, syphilis, tuberculosis) can cause small vessel vasculopathy through direct vessel wall invasion or immune-mediated damage.
Moya diseaseProgressive stenosis of intracranial arteries with compensatory small vessel proliferation.
Sickle cell diseaseChronic hemolytic anemia and vaso-occlusion cause progressive small vessel injury and white matter damage.
Susac syndromeAutoimmune endotheliopathy affecting small vessels of the brain, retina, and inner ear.
Deep/infratentorial CMBsLocated in basal ganglia, thalamus, brainstem, or cerebellum; associated with hypertensive arteriopathy and increased risk of deep intracerebral hemorrhage.
Strictly lobar CMBsLocated in cortical-subcortical regions; suggest cerebral-amyloid-angiopathy (CAA) and are associated with lobar hemorrhage risk and alzheimers.
Mixed patternBoth deep and lobar CMBs; may reflect combined hypertensive and amyloid pathology.
Cortical atrophyWidespread cortical thinning, particularly in frontal and parietal regions, correlates with executive dysfunction and processing speed decline.
DatabasesOMIMOrphanetClinicalTrialsPubMed

No AI portrait yet

Knowledge Graph

Agent Input

Related Hypotheses (18)

Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79
Competitive APOE4 Domain Stabilization Peptides
Score: 0.78
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.72
Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.86
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.78
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.76
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.76
GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.75
APOE Isoform Expression Across Glial Subtypes
Score: 0.74
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.74
Aquaporin-4 Polarization Rescue
Score: 0.73
Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.73
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.72
APOE Isoform Conversion Therapy
Score: 0.72
Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.71
Metabolic Circuit Breaker via Lipid Droplet Modulation
Score: 0.71
Circadian-Gated Maresin Biosynthesis Amplification
Score: 0.56
Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54

Related Analyses (16)

Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed

Related Experiments (8)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40
Vascular Contributions to Alzheimer Disease and Mixed Pathol
clinical · proposed · Score: 0.40
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...